Strike The Right Regulatory Balance To Promote Generic Medicines And Future Innovation

The America Invents Act (2011) has upset the careful balance that had simultaneously promoted greater use of generics medicines and continued pharmaceutical innovation. Congress should recognize the different patent needs of pharmaceutical and technology companies.March 14, 2018 at 12:59PM

via Forbes Real Time